Received Oct 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | — |
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | UNK | — | — |
long covid; This spontaneous case was reported by a consumer and describes the occurrence of POST-ACUTE COVID-19 SYNDROME (long covid) in a patient of an unknown age and gender who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Co-suspect product included non-company product Tozinameran (Pfizer BioNTech COVID-19 vaccine) for an unknown indication. No Medical History information was reported. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form and dose of Tozinameran (Pfizer BioNTech COVID-19 vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced POST-ACUTE COVID-19 SYNDROME (long covid). At the time of the report, POST-ACUTE COVID-19 SYNDROME (long covid) outcome was unknown. The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown. No concomitant medication was reported. The reporter queried about the availability of Novavax vaccine. Patient had not yet received the Novavax vaccine, because appointment was scheduled for patient to get a vaccine, but the patient wanted to receive only Novavax vaccine. The patient felt grateful to have that option of getting Novavax vaccine because, patient was able to take Pfizer and Moderna vaccines for a while, but then the patient had long Covid. And since the patient got long Covid, it caused some problems for the patient. So, the patient needed to receive Novavax vaccine which would work just fine for the patient. No treatment information was reported.